These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36157476)

  • 1. Targeting BMI1 mitigates chemoresistance in ovarian cancer.
    Dey A; Dhar Dwivedi SK; Wang L; Hossen MN; Neizer-Ashun F; Bieniasz M; Mukherjee P; Baird JD; Weetall M; Bhattacharya R
    Genes Dis; 2022 Nov; 9(6):1415-1418. PubMed ID: 36157476
    [No Abstract]   [Full Text] [Related]  

  • 2. TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance.
    Ren H; Du P; Ge Z; Jin Y; Ding D; Liu X; Zou Q
    J Cancer; 2016; 7(9):1074-80. PubMed ID: 27326250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMI1 activates P-glycoprotein via transcription repression of
    Chen MK; Zhou JH; Wang P; Ye YL; Liu Y; Zhou JW; Chen ZJ; Yang JK; Liao DY; Liang ZJ; Xie X; Zhou QZ; Xue KY; Guo WB; Xia M; Bao JM; Yang C; Duan HF; Wang HY; Huang ZP; Qin ZK; Liu CD
    Aging (Albany NY); 2021 Jul; 13(14):18310-18330. PubMed ID: 34270461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.
    Ge G; Zhou C; Ren Y; Tang X; Wang K; Zhang W; Niu L; Zhou Y; Yan Y; He J
    Tumour Biol; 2016 Apr; 37(4):5049-62. PubMed ID: 26546432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-inhibition of BMI1 and Mel18 enhances chemosensitivity of esophageal squamous cell carcinoma
    Wang J; Ji H; Zhu Q; Yu X; Du J; Jiang Z
    Oncol Lett; 2019 Jun; 17(6):5012-5022. PubMed ID: 31186712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bmi1 essentially mediates podocalyxin-enhanced Cisplatin chemoresistance in oral tongue squamous cell carcinoma.
    Zhou Y; Zhang L; Pan H; Wang B; Yan F; Fang X; Munnee K; Tang Z
    PLoS One; 2015; 10(4):e0123208. PubMed ID: 25915207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences.
    Siddique HR; Saleem M
    Stem Cells; 2012 Mar; 30(3):372-8. PubMed ID: 22252887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance.
    Shahi MH; Farheen S; Mariyath MP; Castresana JS
    Tumour Biol; 2016 Nov; 37(11):15107-15114. PubMed ID: 27662839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Fluorouracil chemotherapy of gastric cancer generates residual cells with properties of cancer stem cells.
    Xu ZY; Tang JN; Xie HX; Du YA; Huang L; Yu PF; Cheng XD
    Int J Biol Sci; 2015; 11(3):284-94. PubMed ID: 25678847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of BMI1 in epithelial ovarian cancer: investigated via the CRISPR/Cas9 system and RNA sequencing.
    Zhao Q; Qian Q; Cao D; Yang J; Gui T; Shen K
    J Ovarian Res; 2018 Apr; 11(1):31. PubMed ID: 29685168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistance.
    Ferretti R; Bhutkar A; McNamara MC; Lees JA
    Genes Dev; 2016 Jan; 30(1):18-33. PubMed ID: 26679841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMI1 polycomb group protein acts as a master switch for growth and death of tumor cells: regulates TCF4-transcriptional factor-induced BCL2 signaling.
    Siddique HR; Parray A; Tarapore RS; Wang L; Mukhtar H; Karnes RJ; Deng Y; Konety BR; Saleem M
    PLoS One; 2013; 8(5):e60664. PubMed ID: 23671559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircRNA DONSON contributes to cisplatin resistance in gastric cancer cells by regulating miR-802/BMI1 axis.
    Liu Y; Xu J; Jiang M; Ni L; Ling Y
    Cancer Cell Int; 2020; 20():261. PubMed ID: 32581651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
    Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B
    J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of BMI1 induces autophagy-mediated necroptosis.
    Dey A; Mustafi SB; Saha S; Kumar Dhar Dwivedi S; Mukherjee P; Bhattacharya R
    Autophagy; 2016; 12(4):659-70. PubMed ID: 27050456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling.
    Qian J; LeSavage BL; Hubka KM; Ma C; Natarajan S; Eggold JT; Xiao Y; Fuh KC; Krishnan V; Enejder A; Heilshorn SC; Dorigo O; Rankin EB
    J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34396988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing Bmi1 expression suppresses cancer stemness and enhances chemosensitivity in endometrial cancer cells.
    Kim M; Lee S; Park WH; Suh DH; Kim K; Kim YB; No JH
    Biomed Pharmacother; 2018 Dec; 108():584-589. PubMed ID: 30243092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.
    Yin T; Zhang Z; Cao B; Duan Q; Shi P; Zhao H; Camara SN; Shen Q; Wang C
    Oncotarget; 2016 Jun; 7(24):37192-37204. PubMed ID: 27177084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential signaling pathways as therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer.
    Niiro E; Morioka S; Iwai K; Yamada Y; Ogawa K; Kawahara N; Kobayashi H
    Biomed Rep; 2018 Mar; 8(3):215-223. PubMed ID: 29564122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLK1 inhibition down-regulates polycomb group protein BMI1 via modulation of the miR-200c/141 cluster.
    Dimri M; Cho JH; Kang M; Dimri GP
    J Biol Chem; 2015 Jan; 290(5):3033-44. PubMed ID: 25505268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.